Literature DB >> 1339301

Molecular cloning and characterisation of a human brain A1 adenosine receptor cDNA.

A Townsend-Nicholson1, J Shine.   

Abstract

Using the sequence conservation in the G protein-coupled receptor superfamily, we have isolated an adenosine A1 receptor cDNA from a human hippocampal cDNA library by homology screening. When expressed in mammalian CHO.K1 cells, the protein encoded by this cDNA binds the A1-specific antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) with high affinity (Kd = 0.56 +/- 0.11 nM) and, functionally, is able to inhibit cAMP production upon receptor activation with the A1-specific agonist N6-cyclopentyladenosine (CPA) (> 80% inhibition at 10(-7) M CPA). The binding and functional characteristics of the expressed cDNA demonstrate that we have isolated a human brain adenosine receptor cDNA of the A1 subtype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339301     DOI: 10.1016/0169-328x(92)90248-a

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  16 in total

1.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

Review 2.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  Synthesis and study of 5'-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist.

Authors:  A Dalpiaz; A Scatturin; E Menegatti; F Bortolotti; B Pavan; C Biondi; E Durini; S Manfredini
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

4.  Coupling of a transfected human brain A1 adenosine receptor in CHO-K1 cells to calcium mobilisation via a pertussis toxin-sensitive mechanism.

Authors:  P A Iredale; S P Alexander; S J Hill
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors.

Authors:  V Sexl; G Mancusi; S Baumgartner-Parzer; W Schütz; M Freissmuth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor.

Authors:  C Dougherty; J Barucha; P R Schofield; K A Jacobson; B T Liang
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

7.  Increased expression of the integral membrane protein ErbB2 in Chinese hamster ovary cells expressing the anti-apoptotic gene Bcl-xL.

Authors:  Shannon O'Connor; Edwin Li; Brian S Majors; Lijuan He; Jesse Placone; Deniz Baycin; Michael J Betenbaugh; Kalina Hristova
Journal:  Protein Expr Purif       Date:  2009-04-17       Impact factor: 1.650

8.  Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity.

Authors:  Gregory D Stewart; Celine Valant; Simon J Dowell; Dalibor Mijaljica; Rodney J Devenish; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Pharmacol Exp Ther       Date:  2009-07-29       Impact factor: 4.030

9.  Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.

Authors:  J M Dickenson; S J Hill
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.

Authors:  S P Alexander; A Losinski; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.